(S (NP (QP (IN Over) (PDT half) (DT a) (CD million)) (NNS individuals)) (VP (VBP are) (VP (VBN diagnosed) (PP (IN with) (NP (NP (NN head)) (CC and) (NP (NP (NN neck) (NN cancer)) (NP (DT each) (NN year))))) (ADVP (RB worldwide)))) (. .))
(S (S (NP (NNP Radiotherapy)) (VP (VBZ is) (NP (NP (DT an) (JJ important) (JJ curative) (NN treatment)) (PP (IN for) (NP (DT this) (NN disease)))))) (, ,) (CC but) (S (NP (PRP it)) (VP (VBZ requires) (NP (NP (ADJP (RB manually) (JJ intensive)) (NN delineation)) (PP (IN of) (NP (NP (NP (JJ radiosensitive) (NNS organs)) (PP (IN at) (NP (NN risk)))) (-LRB- -LRB-) (NP (NNS OARs)) (-RRB- -RRB-)))))) (. .))
(S (NP (DT This) (NN planning) (NN process)) (VP (MD can) (VP (VB delay) (NP (NN treatment) (NN commencement)))) (. .))
(S (SBAR (IN While) (S (NP (NML (NN auto) (HYPH -) (NN segmentation)) (NNS algorithms)) (VP (VBP offer) (NP (DT a) (NML (ADVP (RB potentially))) (NML (NN time) (HYPH -) (NN saving)) (NN solution))))) (, ,) (NP (NP (DT the) (NNS challenges)) (PP (IN in) (S (VP (VBG defining) (, ,) (VBG quantifying) (CC and) (VBG achieving) (NP (JJ expert) (NN performance)))))) (VP (VBP remain)) (. .))
(S (S (VP (VBG Adopting) (NP (DT a) (NML (JJ deep) (NN learning)) (NN approach)))) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (NP (NP (DT a) (NML (NN 3D) (NN U-Net)) (NN architecture)) (SBAR (WHNP (WDT that)) (S (VP (VBZ achieves) (NP (NN performance) (ADJP (JJ similar) (PP (IN to) (NP (NP (NNS experts)) (PP (IN in) (S (VP (VBG delineating) (NP (NP (DT a) (JJ wide) (NN range)) (PP (IN of) (NP (NN head) (CC and) (NN neck)))))))))) (NNS OARs))))))) (. .))
(S (NP (DT The) (NN model)) (VP (VBD was) (VP (VBN trained) (PP (IN on) (NP (NP (DT a) (NN dataset)) (PP (IN of) (NP (NP (CD 663)) (VP (VBN deidentified) (SBAR (S (NP (VBN computed) (NN tomography) (PRN (-LRB- -LRB-) (NP (NN CT)) (-RRB- -RRB-))) (VP (VBZ scans) (VP (VBN acquired) (PP (IN in) (NP (NP (JJ routine) (JJ clinical) (NN practice)) (CC and) (NP (JJ segmented)))) (PP (VBG according) (PP (IN to) (NP (NN consensus) (NN OAR) (NNS definitions))))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP demonstrate) (NP (PRP$ its) (NN generalisability)) (PP (IN through) (NP (NP (NN application)) (PP (IN to) (NP (NP (DT an) (JJ independent) (NN test) (NN set)) (PP (IN of) (NP (NML (CD 24) (NN CT)) (NNS scans))))))) (S (ADJP (JJ available) (PP (IN from) (NP (DT The) (NNP Cancer) (NNP Imaging) (NNP Archive)))) (SBAR (SINV (VP (VP (VBD collected) (PP (IN at) (NP (NP (JJ multiple) (JJ international) (NNS sites)) (ADJP (RB previously) (JJ unseen)))) (PP (IN to) (NP (NP (DT the) (NN model)) (, ,) (NP (DT each) (JJ segmented)))) (PP (IN by) (NP (CD two) (JJ independent) (NNS experts)))) (CC and) (VP (VBG consisting) (PP (IN of) (NP (CD 21) (NNS OARs))) (ADVP (RB commonly)))) (NP (NP (JJ segmented)) (PP (IN in) (NP (JJ clinical) (NN practice)))))))) (. .))
(S (PP (IN With) (NP (NP (JJ appropriate) (NN validation) (NNS studies)) (CC and) (NP (JJ regulatory) (NNS approvals)))) (, ,) (NP (DT this) (NN system)) (VP (MD could) (VP (VB improve) (NP (NP (DT the) (NN effectiveness)) (PP (IN of) (NP (NN radiotherapy) (NNS pathways)))))) (. .))
